Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
153 EUR | +1.36% |
|
-1.80% | +14.85% |
12/07 | UBS Raises Price Target on Procter & Gamble to $191 From $183, Maintains Buy Rating | MT |
10/07 | Citigroup Adjusts Procter & Gamble's Price Target to $190 From $177 | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- With a 2024 P/E ratio at 26.58 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.85% | 388B | - | ||
+22.11% | 79.79B | A+ | ||
+0.99% | 73.63B | A- | ||
-31.08% | 36.23B | B+ | ||
-15.05% | 34.68B | - | ||
+0.11% | 33.31B | B- | ||
+11.84% | 18.44B | A- | ||
+28.43% | 17.58B | B | ||
+15.03% | 13.41B | C+ | ||
+23.57% | 10.09B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PG Stock
- PRG Stock
- Ratings Procter & Gamble Company